It's typically used at concentrations up to 1.9% in leave-on products
Symptoms can manifest 10 to 15 years before menopause, signaling fluctuating estrogen levels
IV therapy presents a promising avenue for addressing adrenal fatigue, a condition often associated with chronic stress and adrenal dysfunction
[DOI] [PubMed] [Google Scholar] 126.Baier P.C., Weinhold S.L., Huth V., Gottwald B., Ferstl R., Hinze-Selch D
A study published last summer by JAMA Oncology looked at GLP-1 use and 14 obesity-related cancers and found that while the weight-loss drug lowered the risk of most cancers, there was a nonsignificant increased risk of kidney cancer particularly among people younger than 65
RuddKEJohnsonSCAgesaKMShackelfordKATsoiDKievlanDRet al